Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(1)
About
Natco Pharma Ltd.
NSE: NATCOPHARM
|
BSE: 524816
|
ISIN: INE987B01026
|
Industry: Pharmaceuticals
US FDA Observation
|
Strong Performer, Under Radar
878.2000
5.35
(
0.61
%)
NSE
Jun 18, 2025
15:31 PM
46.42% Fall from 52W High
Volume:
610.7K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Natco Pharma Ltd.
19 Mar 2025, 12:00AM
US FDA Observation
878.20
0.61%
NATCO PHARMA
Hold:
Natco Pharma Ltd.
by
Geojit BNP Paribas
Target: 887 | Target met
Target
Geojit BNP Paribas
Geojit BNP Paribas increased Hold price target of Natco Pharma Ltd. to 952.0 on 11 Jun, 2025.
More from Natco Pharma Ltd.
Recommended
Chart of the Week: Profit booking grips promoters as stake sales surge across sectors
The Baseline |
18 Jun 2025, 05:06PM
Market closes lower, HDFC Bank CEO challenges FIR over disputed loan disclosure
Trendlyne Marketwatch |
18 Jun 2025, 03:58PM
Earnings Call Transcript - Q4FY20 for Natco Pharma
|
18 Jun 2020, 06:25PM